L&T Technology Services Ltd Q3 FY26 – ₹2,924 Cr Revenue, ₹303 Cr Profit, 18% OPM & the Curious Case of a Premium Engineer
1. At a Glance – The Engineer Who Charges Like a Consultant
L&T Technology Services Ltd is that overachieving engineering kid in class who not only tops exams but also charges tuition fees higher than the teacher. As of mid-January 2026, the company flexes a market capitalisation of ₹44,980 Cr, trades at ₹4,244, and commands a P/E of ~35x—a valuation that screams “quality” to some and “overconfidence” to others. The latest Q3 FY26 numbers show revenue of ₹2,924 Cr, up 10.2% YoY, while PAT came in at ₹303 Cr, growing a much calmer 1.81% YoY. Operating margins bounced back to 18%, after flirting with 16% levels earlier, reminding investors that cost discipline still exists somewhere in the organisation. With ROCE at 28.3%, ROE at 22.2%, and debt-to-equity of just 0.10, LTTS looks financially fitter than most IT cousins who survive on caffeine and cost cutting. But the stock has delivered -12.5% return over 1 year, leaving shareholders emotionally confused—great company, meh stock performance. So the obvious question arises: is LTTS just catching its breath, or is the market finally questioning the price tag on premium engineering?
2. Introduction – Not Your Regular IT Coolie
Let’s be clear. LTTS is not Infosys with a hard hat, nor TCS with CAD software. This is a pure-play ER&D company, born out of the Larsen & Toubro ecosystem in 2012 and listed in 2016. Its job is to design, engineer, simulate, test, digitise, and sometimes babysit products that cost more than your entire neighbourhood. From medical devices that must not fail, to aerospace and automotive systems that absolutely must not fail, LTTS sells brainpower—not body shopping.
The company services 378 active clients across 25+ countries, including 69 Fortune 500 companies and 57 of the world’s top ER&D spenders. Translation: these clients don’t negotiate like your average procurement uncle. They demand quality, compliance, IP protection, and innovation. And they pay… slowly but surely.
Q3 FY26 arrived with respectable topline growth but slightly underwhelming profit growth, mainly due to wage hikes, integration costs of Intelliswift, and margin pressure in some verticals. Yet, LTTS continues to sign chunky deals, expand its hyperscaler alliances, and hoard patents like Pokémon cards (1,448 patents as of Q3 FY25).
So why is the stock sulking while the company keeps winning deals? Is the market bored of ER&D? Or is this just a valuation digestion phase? Hold that thought.
3. Business Model – WTF Do They Even Do?
Imagine a German automotive OEM, a US medical device company, and a global energy major walk into a room. None of them want IT support. They want engineering brains. LTTS walks in wearing a lab coat and invoices them in dollars.
The company operates through three core segments:
Tech (35% of 9M FY25 revenue)
This is where software meets silicon. LTTS builds and maintains software, hardware, firmware, and platforms for MedTech, semiconductors, consumer electronics, hyperscalers, and next-gen communications. Revenue here grew 6% YoY in 9M FY25, driven by medical devices and cloud players. Think less “app development” and more “FDA-compliant life-saving tech”.
Mobility (34%)
This is LTTS’s adrenaline zone—automotive, aerospace, rail, trucks, and off-highway vehicles. From concept design to manufacturing support, the company helps OEMs reduce costs, improve efficiency, and survive the EV transition. This segment clocked 12% YoY growth in 9M FY25, making it the fastest-growing vertical.
Sustainability (31%)
Here LTTS plays with industrial machinery, power, buildings, oil & gas, and FMCG—modernising plants, automating processes, and improving energy efficiency. Growth stood at 6% YoY, supported by plant modernisation demand.
The revenue mix is diversifying geographically too. North America now contributes 52%, down from 63% in
